Make RSV vaccines available to newborns without delay

Dr. Permar and Dr. Acker detail two highly effective RSV vaccines that can safely reduce RSV disease in the first year of life. Both are currently being studied for newborns. “The development of both RSV vaccines was led by pediatric researchers who understood the burden of disease in children caused by RSV,” they write. “But approval processes for critical interventions to RSV have been harrowing, even as the next viral respiratory season looms.

They conclude: “Paediatricians often need to be the voice of children. So we ask on their behalf now: make RSV vaccines for newborns available without delay and before they fill pediatric ERs and hospitals across the country. »

Read the full articlehere.